Dianthus Therapeutics | MGTA - Capital Ordinário





Capital Ordinário Alterar Data
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.38M 172K 2026-03
Celltrion KRW 218.61M 162.21K 2025-12
Cspc Pharmaceutical CNY 11.52B 3.7M 2025-12
Deva Holding AS TRY 200.02M 0 2023-09
Dianthus Therapeutics USD 43.22M 368.53K 2025-12
Divis Laboratories Ltd INR 265.47M 0 2026-03
IQVIA Holdings USD 166.9M 2.7M 2026-03
Kangmei Pharma CNY 13.83B 0 2026-03
Knight Therapeutics CAD 99.68M 24.66K 2025-09
Laboratorios Farma EUR 51.82M 1.55M 2023-12
Malin Corporation EUR 200K 0 2024-12
Medical Developments International AUD 112.66M 2.35M 2025-12
Moderna USD 391M 2M 2025-09
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Organigram Holdings CAD 135.13M 671.75K 2025-12
Organon & Co USD 260.32M 333K 2025-12
Ovoca Bio EUR 29.49M 18.43M 2025-06
Pharma Mar EUR 17.36M 0 2026-03
Qiagen NV USD 216.56M 284.67K 2025-12
Revvity USD 111.8M 1.57M 2026-03
Sartorius EUR 69.05M 0 2026-03
Sino Biopharmaceutical CNY 17.89B 30.5M 2025-06
Tectonic Therapeutic USD 18.74M 25.03K 2025-12
Tilray USD 116.52M 5.01M 2025-09
Viatris USD 1.16B 5.27M 2026-03
Xeris Pharmaceuticals USD 166.22M 687.16K 2025-12
Zealand Pharma A/S 70.61M 319.68K 2025-12
Zz Pientze Pharmaceu CNY 603.32M 0 2026-03